Table 5.
Association between rs1128503 and susceptibility to T2DM.
| Genetic model | Patient group | Control group | OR (95% CI) | P | OR (95% CI)* | P* | ||
|---|---|---|---|---|---|---|---|---|
| TC vs TT | 449 (41%) | 536 (49%) | 444 (40%) | 572 (51%) | 1.079 (0.905–1.287) | 0.397 | 1.081 (0.907–1.278) | 0.467 |
| CC vs TT | 101 (9%) | 536 (49%) | 106 (9%) | 572 (51%) | 1.017 (0.756–1.368) | 0.912 | 1.021 (0.732–1.385) | 0.914 |
| C vs T | 651 (30%) | 1521 (70%) | 656 (29%) | 1588 (71%) | 1.036 (0.910–1.179) | 0.591 | 1.040 (0.907–1.183) | 0.602 |
| Dominant | 550 (51%) | 536 (49%) | 550 (49%) | 572 (51%) | 1.067 (0.903–1.261) | 0.445 | 1.074 (0.932–1.285) | 0.467 |
| Recessive | 101 (9%) | 985 (91%) | 106 (9%) | 1016 (91%) | 0.983 (0.738–1.309) | 0.906 | 0.092 (0.740–1.315) | 0.912 |
T2DM, type 2 diabetes mellitus; OR, odds ratio; CI, confidence interval; BMI, body mass index; HbA1c, glycated hemoglobin.
*Represents the values after adjustment for age, sex, BMI, blood pressure, and HbA1c.